ARTBIO

ARTBIO

Biotechnology Research

Cambridge, Massachusetts 7,344 followers

Empowering patient-centric advances in cancer care

About us

ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.

Website
www.artbio.com
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Cambridge, Massachusetts
Type
Privately Held

Locations

Employees at ARTBIO

Updates

Similar pages

Funding

ARTBIO 2 total rounds

Last Round

Series A

US$ 90.0M

See more info on crunchbase